Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes - PubMed (original) (raw)

Review

. 2003 Sep;78(3 Suppl):617S-625S.

doi: 10.1093/ajcn/78.3.617S.

Affiliations

• PMID: 12936956
• DOI: 10.1093/ajcn/78.3.617S

Review

Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes

Emilio Ros. Am J Clin Nutr. 2003 Sep.

Abstract

Whether low-fat, high-carbohydrate (CHO) diets or moderately high-fat, high-monounsaturated fatty acid (MUFA) diets are preferable for the treatment and prevention of diabetes has been a matter of debate. High-fat diets based on MUFA-rich oils or whole foods have been compared with high-CHO diets for effects on several cardiovascular risk outcomes in diabetic subjects. Early studies using metabolic diets with wide differences in total fat content (15-25% of energy) generally found a beneficial effect of MUFA diets on glycemic control and serum lipids. Recent studies using prescribed diets with a difference of </= 15% of energy in total fat between low-fat and high-MUFA diets show similar effects on glycemic profiles but still favor MUFA diets for effects on triacylglycerols and HDL cholesterol. It is unclear whether postprandial fat clearance is impaired by CHO diets and improved by MUFA diets, independent of effects on fasting triacylglycerol concentrations. Unless one diet contains abundant antioxidants, the 2 dietary approaches appear to have similar effects on LDL oxidation. Low-fat diets, however, are associated with atherogenic, dense LDL particles, while normal, buoyant LDL predominate with high-fat diets irrespective of fatty acid composition. Limited experimental evidence suggests that MUFA diets favorably influence blood pressure, coagulation, endothelial activation, inflammation, and thermogenic capacity. Energy-controlled high-MUFA diets do not promote weight gain and are more acceptable than low-fat diets for weight loss in obese subjects. Thus, there is good scientific support for MUFA diets as an alternative to low-fat diets for medical nutrition therapy in diabetes.

PubMed Disclaimer

Similar articles

• Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
  Rodríguez-Villar C, Pérez-Heras A, Mercadé I, Casals E, Ros E. Rodríguez-Villar C, et al. Diabet Med. 2004 Feb;21(2):142-9. doi: 10.1046/j.1464-5491.2003.01086.x. Diabet Med. 2004. PMID: 14984449 Clinical Trial.
• Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
  Gumbiner B, Low CC, Reaven PD. Gumbiner B, et al. Diabetes Care. 1998 Jan;21(1):9-15. doi: 10.2337/diacare.21.1.9. Diabetes Care. 1998. PMID: 9538963 Clinical Trial.
• Reduction in liver fat by dietary MUFA in type 2 diabetes is helped by enhanced hepatic fat oxidation.
  Bozzetto L, Costabile G, Luongo D, Naviglio D, Cicala V, Piantadosi C, Patti L, Cipriano P, Annuzzi G, Rivellese AA. Bozzetto L, et al. Diabetologia. 2016 Dec;59(12):2697-2701. doi: 10.1007/s00125-016-4110-5. Epub 2016 Sep 20. Diabetologia. 2016. PMID: 27650287 Clinical Trial.
• Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses.
  Schwingshackl L, Hoffmann G. Schwingshackl L, et al. Nutrients. 2012 Dec 11;4(12):1989-2007. doi: 10.3390/nu4121989. Nutrients. 2012. PMID: 23363996 Free PMC article. Review.

Cited by

• 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.
  American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005. Diabetes Care. 2024. PMID: 38078584 Free PMC article. Review.
• An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus.
  Mahgoub MO, Ali II, Adeghate JO, Tekes K, Kalász H, Adeghate EA. Mahgoub MO, et al. Int J Mol Sci. 2023 May 26;24(11):9328. doi: 10.3390/ijms24119328. Int J Mol Sci. 2023. PMID: 37298274 Free PMC article. Review.
• Characterization of Shrimp Oil from Pandalus borealis by High Performance Liquid Chromatography and High Resolution Mass Spectrometry.
  Jiao G, Hui JP, Burton IW, Thibault MH, Pelletier C, Boudreau J, Tchoukanova N, Subramanian B, Djaoued Y, Ewart S, Gagnon J, Ewart KV, Zhang J. Jiao G, et al. Mar Drugs. 2015 Jun 18;13(6):3849-76. doi: 10.3390/md13063849. Mar Drugs. 2015. PMID: 26096274 Free PMC article.
• Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.
  Wang YH, Lin CW, Huang CW. Wang YH, et al. Biomedicines. 2024 Sep 12;12(9):2085. doi: 10.3390/biomedicines12092085. Biomedicines. 2024. PMID: 39335598 Free PMC article. Review.
• The impact of nuts on diabetes and diabetes risk.
  Lovejoy JC. Lovejoy JC. Curr Diab Rep. 2005 Oct;5(5):379-84. doi: 10.1007/s11892-005-0097-x. Curr Diab Rep. 2005. PMID: 16188174 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information